SCHEMBL1370741

SCHEMBL1370741

CCc1cc(Cl)ncn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16033555 0.82 KDM4E (0.42)
SCHEMBL1767952 0.82 HRH4 (0.41)
SCHEMBL15057849 0.79 GABRA2 (0.38)
SCHEMBL7982137 0.78
SCHEMBL1444830 0.77 KCNH2 (0.41)
SCHEMBL16340550 0.77 NOS3 (0.40)
SCHEMBL374273 0.76
SCHEMBL1660131 0.76
SCHEMBL4536920 0.76
SCHEMBL1661258 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3986553-B1 CYCLOBUTYL CARBOXYLIC ACIDS AS LPA ANTAGONISTS BRISTOL MYERS SQUIBB CO (US) 2026-03-25 EP disclosed
US-20260028365-A1 TYROSINE KINASE 2 INHIBITORS AND USES THEREOF BIOGEN MA INC (US) 2026-01-29 US disclosed
US-12466804-B2 Cyclobutyl carboxylic acids as LPA antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 2025-11-11 US disclosed
EP-4543890-A1 USP1 INHIBITORS AND USES THEREOF Forma Therapeutics, Inc. (US) 2025-04-30 EP disclosed
CN-119731178-A USP1 inhibitors and uses thereof 福马治疗有限公司 2025-03-28 CN disclosed
US-20240317725-A1 LPA1 SMALL MOLECULE ANTAGONIST TUOJIE BIOTECH (SHANGHAI) CO., LTD. (CN) 2024-09-26 US disclosed
CN-112055711-B Cyclohexylic acid triazolazine as LPA antagonist 百时美施贵宝公司 2024-07-23 CN disclosed
US-20240228488-A1 HETEROARYL INHIBITORS OF PLASMA KALLIKREIN TAKEDA PHARMACEUTICALS CO (JP) 2024-07-11 US disclosed
EP-4375277-A1 LPA1 SMALL MOLECULE ANTAGONIST Tuojie Biotech (Shanghai) Co., Ltd. (CN) 2024-05-29 EP disclosed
US-20240124444-A1 Heterocyclic Compounds and Their Use for Parasitic Diseases CELGENE CORPORATION (US) 2024-04-18 US disclosed
US-5688791-A COMPOUNDS FOR TREATMENNT OF VIRAL DISEASES SUCH AS AIDS UBE INDUSTRIES, LTD. (JP) 1997-11-18 US disclosed
EP-0470600-B1 Naphthylalkylaminopyrimidine derivatives, process for their preparation and pesticides containing them CIBA GEIGY AG (CH) 1997-05-07 EP disclosed
WO-1997006160-A1 PREPARATION OF TRIAZOLES BY ORGANOMETALLIC ADDITION TO KETONES AND INTERMEDIATES THEREFOR PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-02-20 WO disclosed
WO-1997001552-A1 TRIAZOLE ANTIFUNGAL AGENTS PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-01-16 WO disclosed
US-5519016-A Aryl group- or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-HIV agent UBE INDUSTRIES, LTD. (JP) 1996-05-21 US disclosed
US-5468751-A Aminopyrimidine derivatives as microbicides, insecticides and acaricides CIBA-GEIGY CORPORATION (US) 1995-11-21 US disclosed
CN-1086515-A Aminoquinolone derivative and anti-hiv agent that aryl or fragrant heterocyclic radical replace UBE INDUSTRIES (JP) 1994-05-11 CN disclosed
EP-0572259-A1 Aminoquinolone derivatives as anti-HIV agents UBE INDUSTRIES, LTD. (JP) 1993-12-01 EP disclosed
WO-1993022291-A1 ARTHROPODICIDAL AND FUNGICIDAL AMINOPYRIMIDINES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1993-11-11 WO disclosed
EP-0470600-A1 Naphthylalkylaminopyrimidine derivatives, process for their preparation and pesticides containing them CIBA-GEIGY AG (CH) 1992-02-12 EP disclosed